Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Yong-Chen Lu

Concepts (229)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
13
2022
146
4.260
Why?
Receptors, Antigen, T-Cell
10
2022
49
3.120
Why?
Lymphocytes, Tumor-Infiltrating
17
2022
75
3.050
Why?
Immunotherapy
6
2024
235
2.530
Why?
Immunotherapy, Adoptive
8
2019
158
2.530
Why?
T-Lymphocytes
9
2022
328
2.530
Why?
Neoplasms
10
2024
1234
2.470
Why?
CD4-Positive T-Lymphocytes
5
2024
157
1.650
Why?
Cancer Vaccines
4
2021
78
1.430
Why?
High-Throughput Nucleotide Sequencing
3
2021
168
1.270
Why?
Mutation
12
2019
1292
0.950
Why?
Single-Cell Analysis
3
2022
63
0.780
Why?
CD8-Positive T-Lymphocytes
8
2024
124
0.710
Why?
Immune System
1
2020
43
0.700
Why?
Alcohol Oxidoreductases
1
2019
13
0.660
Why?
HLA-DP beta-Chains
2
2017
2
0.620
Why?
Neoplasm Proteins
2
2017
321
0.600
Why?
Urinary Bladder Neoplasms
1
2019
158
0.580
Why?
Genetic Therapy
2
2017
117
0.570
Why?
DNA-Binding Proteins
1
2019
424
0.530
Why?
Melanoma
3
2016
281
0.530
Why?
Humans
36
2025
49922
0.500
Why?
Animals
15
2024
13100
0.490
Why?
Immunodominant Epitopes
2
2015
8
0.470
Why?
Proto-Oncogene Proteins p21(ras)
4
2019
66
0.470
Why?
Signal Transduction
7
2024
1608
0.470
Why?
Protein Phosphatase 1
1
2013
7
0.440
Why?
Cytokines
4
2019
607
0.440
Why?
Phosphoprotein Phosphatases
1
2013
17
0.430
Why?
Osteoarthritis
2
2024
61
0.430
Why?
Lymphocyte Activation
5
2021
171
0.430
Why?
Proto-Oncogene Proteins c-rel
2
2010
5
0.420
Why?
Antibodies, Monoclonal
1
2016
457
0.400
Why?
Colorectal Neoplasms
3
2019
253
0.370
Why?
Neoplasm Metastasis
3
2022
235
0.360
Why?
CCAAT-Enhancer-Binding Protein-beta
1
2009
4
0.330
Why?
Toll-Like Receptors
1
2009
27
0.330
Why?
Transcriptome
2
2022
312
0.330
Why?
CCAAT-Enhancer-Binding Protein-delta
1
2009
22
0.320
Why?
Lipopolysaccharides
2
2022
195
0.320
Why?
Glioblastoma
2
2021
88
0.320
Why?
Toll-Like Receptor 4
1
2008
51
0.290
Why?
Adoptive Transfer
3
2018
30
0.260
Why?
Cells, Cultured
5
2021
1587
0.260
Why?
Gene Expression Profiling
2
2021
1028
0.250
Why?
Sarcoma, Synovial
1
2025
4
0.250
Why?
Autoantigens
2
2015
50
0.240
Why?
Nanofibers
1
2024
7
0.240
Why?
Bioprinting
1
2024
2
0.240
Why?
Skin, Artificial
1
2024
10
0.230
Why?
Nutrition Surveys
1
2024
101
0.230
Why?
Humerus
1
2024
18
0.230
Why?
T-Lymphocytes, Regulatory
2
2016
82
0.230
Why?
Geriatric Assessment
1
2024
112
0.230
Why?
Gene Library
2
2014
42
0.230
Why?
Nutritional Status
1
2024
136
0.230
Why?
Sarcopenia
1
2024
91
0.220
Why?
Receptors, Estrogen
1
2024
130
0.220
Why?
Adipocytes
1
2024
121
0.220
Why?
beta Catenin
1
2024
101
0.210
Why?
Leptin
1
2024
137
0.210
Why?
Thyroid Neoplasms
1
2024
112
0.200
Why?
Nephritis
1
2022
22
0.200
Why?
Clone Cells
2
2019
78
0.200
Why?
Bone Marrow
1
2024
351
0.200
Why?
Receptors, Immunologic
1
2022
37
0.200
Why?
Middle Aged
9
2024
12289
0.200
Why?
Bone Neoplasms
1
2024
178
0.200
Why?
Ureteral Obstruction
1
2022
61
0.190
Why?
HLA-A Antigens
2
2019
10
0.190
Why?
Osteogenesis
1
2024
353
0.190
Why?
Human papillomavirus 16
1
2021
44
0.190
Why?
Adaptor Proteins, Signal Transducing
2
2014
197
0.190
Why?
Tumor Suppressor Protein p53
2
2022
213
0.190
Why?
T-Cell Antigen Receptor Specificity
2
2017
4
0.180
Why?
Membrane Glycoproteins
1
2022
244
0.180
Why?
Papillomavirus Vaccines
1
2021
67
0.180
Why?
Interleukin-2
2
2017
70
0.170
Why?
Female
14
2025
26571
0.170
Why?
Aged
4
2024
9448
0.160
Why?
Smad5 Protein
1
2019
1
0.160
Why?
Mucin-4
1
2019
1
0.160
Why?
Renal Insufficiency, Chronic
1
2022
170
0.160
Why?
Male
8
2024
25450
0.160
Why?
Uterine Cervical Neoplasms
1
2021
276
0.160
Why?
NF-kappa B
3
2024
315
0.160
Why?
Cell Differentiation
1
2021
649
0.150
Why?
Diabetes Mellitus, Type 2
1
2023
483
0.150
Why?
Epitopes, T-Lymphocyte
2
2014
25
0.140
Why?
Hematopoietic Stem Cell Transplantation
1
2022
554
0.140
Why?
Administration, Intravenous
1
2017
70
0.140
Why?
Mice
6
2024
5658
0.140
Why?
Colonic Neoplasms
1
2019
158
0.140
Why?
Membrane Proteins
1
2019
347
0.140
Why?
Flow Cytometry
3
2016
470
0.140
Why?
Exome
2
2014
45
0.140
Why?
CTLA-4 Antigen
1
2016
23
0.130
Why?
Cell Line, Tumor
2
2017
1388
0.130
Why?
T-Lymphocytes, Helper-Inducer
1
2016
42
0.130
Why?
Gene Expression Regulation
2
2019
964
0.130
Why?
Programmed Cell Death 1 Receptor
1
2016
40
0.130
Why?
Lung Neoplasms
2
2025
601
0.130
Why?
Transcription Factors
1
2019
565
0.130
Why?
Protein Binding
2
2014
656
0.130
Why?
Transplantation, Autologous
1
2017
462
0.130
Why?
Adult
7
2021
13355
0.130
Why?
Gastrointestinal Neoplasms
1
2015
40
0.130
Why?
Treatment Outcome
4
2021
5178
0.120
Why?
Time Factors
2
2021
2891
0.120
Why?
Neutrophils
2
2014
148
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2019
824
0.120
Why?
Respiratory Burst
1
2014
4
0.120
Why?
Hepatitis B e Antigens
1
2014
4
0.120
Why?
Histocompatibility Antigens
1
2014
5
0.120
Why?
Chemotaxis, Leukocyte
1
2014
13
0.120
Why?
Epitope Mapping
1
2014
6
0.120
Why?
Bile Ducts, Intrahepatic
1
2014
15
0.120
Why?
Bile Duct Neoplasms
1
2014
28
0.120
Why?
Cholangiocarcinoma
1
2014
26
0.120
Why?
Th1 Cells
1
2014
53
0.110
Why?
Monocytes
1
2014
131
0.110
Why?
Alleles
1
2014
251
0.110
Why?
Peptides
1
2014
220
0.110
Why?
Amino Acid Sequence
1
2014
579
0.110
Why?
Gene Knockdown Techniques
1
2013
106
0.110
Why?
Genes, T-Cell Receptor
2
2022
5
0.100
Why?
Base Sequence
1
2013
657
0.100
Why?
TNF Receptor-Associated Factor 2
1
2011
4
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
579
0.100
Why?
Molecular Sequence Data
1
2013
799
0.100
Why?
Autoimmunity
1
2011
34
0.100
Why?
Cell Line
1
2014
1010
0.100
Why?
Forkhead Transcription Factors
1
2012
110
0.100
Why?
Disease Progression
1
2014
820
0.090
Why?
Clinical Trials as Topic
1
2013
466
0.090
Why?
Clonal Anergy
1
2010
13
0.090
Why?
Protein Kinase C
1
2010
70
0.090
Why?
Dendritic Cells
2
2022
133
0.080
Why?
Remission Induction
2
2021
205
0.080
Why?
Isoenzymes
1
2010
168
0.080
Why?
Interleukin-1 Receptor-Associated Kinases
1
2009
11
0.080
Why?
Myeloid Differentiation Factor 88
1
2009
33
0.080
Why?
Antineoplastic Agents
1
2017
1175
0.080
Why?
Breast Neoplasms
1
2018
1183
0.080
Why?
Transcriptional Activation
1
2009
121
0.080
Why?
Inflammation Mediators
1
2009
110
0.080
Why?
Antigen Presentation
2
2019
25
0.070
Why?
Cell Separation
2
2019
89
0.070
Why?
Complement C3a
1
2007
3
0.070
Why?
Complement C5a
1
2007
4
0.070
Why?
Mice, Knockout
2
2024
835
0.070
Why?
Macrophages
1
2009
361
0.070
Why?
Fibroblasts
2
2024
352
0.070
Why?
Risk Factors
2
2024
3604
0.060
Why?
Obesity
2
2024
1096
0.060
Why?
Tuberculosis, Spinal
1
2025
5
0.060
Why?
Lymphocyte Count
2
2016
20
0.060
Why?
Spinal Neoplasms
1
2025
30
0.060
Why?
Diagnostic Errors
1
2025
65
0.060
Why?
Gelatin
1
2024
22
0.060
Why?
Nutrition Assessment
1
2024
64
0.060
Why?
Hydrogels
1
2024
17
0.060
Why?
Hyaluronic Acid
1
2024
35
0.060
Why?
Iodine Radioisotopes
1
2024
36
0.060
Why?
Tissue Scaffolds
1
2024
36
0.060
Why?
Hedgehog Proteins
1
2024
33
0.060
Why?
Keratinocytes
1
2024
90
0.060
Why?
Estrogen Receptor alpha
1
2024
86
0.060
Why?
Tissue Engineering
1
2024
67
0.060
Why?
Bone Morphogenetic Proteins
1
2024
56
0.050
Why?
Bone Marrow Cells
1
2024
190
0.050
Why?
Wnt Signaling Pathway
1
2024
91
0.050
Why?
Transforming Growth Factor beta
1
2024
136
0.050
Why?
Swine
1
2024
396
0.050
Why?
Lipid Metabolism
1
2023
175
0.050
Why?
Th17 Cells
1
2022
25
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.050
Why?
Incidence
1
2024
986
0.050
Why?
Prevalence
1
2024
956
0.050
Why?
Neoplasm Grading
1
2021
123
0.050
Why?
Diagnosis, Differential
1
2025
1037
0.050
Why?
Pain
1
2024
374
0.050
Why?
Gene Regulatory Networks
1
2022
107
0.050
Why?
Arginine
1
2022
178
0.050
Why?
Nitric Oxide
1
2022
253
0.040
Why?
Host-Pathogen Interactions
1
2021
136
0.040
Why?
Risk Assessment
1
2024
1254
0.040
Why?
Blotting, Western
2
2011
587
0.040
Why?
Cross-Sectional Studies
1
2024
1574
0.040
Why?
Transduction, Genetic
1
2019
45
0.040
Why?
Immunologic Memory
1
2019
29
0.040
Why?
Mice, Inbred C57BL
1
2024
1777
0.040
Why?
Lung
2
2016
501
0.040
Why?
Transplantation Conditioning
1
2019
82
0.040
Why?
Coculture Techniques
1
2019
143
0.040
Why?
Phenotype
2
2012
728
0.040
Why?
Neoplastic Cells, Circulating
1
2019
74
0.040
Why?
Molecular Targeted Therapy
1
2019
121
0.040
Why?
Lymphatic Metastasis
1
2019
226
0.040
Why?
Cell Proliferation
1
2021
986
0.040
Why?
Proteasome Endopeptidase Complex
1
2018
116
0.040
Why?
HLA-DRB1 Chains
1
2017
5
0.040
Why?
Antigen-Presenting Cells
1
2017
24
0.040
Why?
Aged, 80 and over
1
2024
3137
0.040
Why?
Pilot Projects
1
2019
702
0.030
Why?
Cross Reactions
1
2016
41
0.030
Why?
HLA-C Antigens
1
2015
4
0.030
Why?
ras Proteins
1
2015
65
0.030
Why?
Inflammation
2
2011
603
0.030
Why?
Young Adult
1
2025
4031
0.030
Why?
Proto-Oncogene Proteins
1
2015
155
0.030
Why?
Clinical Trials, Phase II as Topic
1
2014
46
0.030
Why?
Chemokines
1
2014
75
0.030
Why?
Vaccination
1
2016
275
0.030
Why?
Receptor, erbB-2
1
2014
74
0.030
Why?
United States
1
2024
4880
0.030
Why?
B-Lymphocytes
1
2014
175
0.030
Why?
Recombinant Proteins
1
2014
482
0.030
Why?
Dose-Response Relationship, Immunologic
1
2012
13
0.030
Why?
Whole-Body Irradiation
1
2012
129
0.020
Why?
Polymerase Chain Reaction
1
2011
456
0.020
Why?
Apoptosis
1
2014
1092
0.020
Why?
Mice, Transgenic
1
2010
543
0.020
Why?
Receptor, Anaphylatoxin C5a
1
2007
3
0.020
Why?
Receptors, Chemokine
1
2007
13
0.020
Why?
Complement Activation
1
2007
24
0.020
Why?
Cattle
1
2007
207
0.020
Why?
Actins
1
2007
115
0.020
Why?
Hematopoietic Stem Cells
1
2007
182
0.020
Why?
Lu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description